Prospective, multicenter, open-labeled, phase II study of clinical effect of the combination of metformin and standard chemotherapy in patient with newly diagnosed with T-cell lymphoma and the role of AMP-activated protein kinase (AMPK)
Not Applicable
- Conditions
- Neoplasms
- Registration Number
- KCT0007442
- Lead Sponsor
- Kyungpook National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
not applicable
Exclusion Criteria
not applicable
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Event free survival
- Secondary Outcome Measures
Name Time Method Overall survival